Healthy donors | Bladder cancer patients | |
---|---|---|
51Cr-release assay | ||
HT-1376 | 80.12 ± 4.14 % | 38.67 ± 8.88 %*** |
HT-1376 spheres | 75.44 ± 6.53 % | 11.74 ± 3.12 %*** |
UM-UC3 | 73.69 ± 5.40 % | 41.38 ± 10.71 %** |
UM-UC3 spheres | 67.52 ± 7.61 % | 18.19 ± 4.17 %*** |
NCRs | ||
NKp30 | 54.68 ± 4.98 % | 33.55 ± 5.09 %* |
NKp44 | 26.35 ± 9.18 % | 0.52 ± 0.20 %*** |
NKp46 | 42.93 ± 3.70 % | 49.09 ± 6.09 % |
NKp80 | 98.34 ± 0.32 % | 91.36 ± 2.20 %** |
CD62L | 33.40 ± 1.44 % | 24.30 ± 2.57 %* |
CD57 | 31.08 ± 2.54 % | 20.86 ± 2.14 %** |
Cytokines | ||
TNF-α | 0.36 ± 0.13 % | 0.23 ± 0.08 % |
IFN-γ | 0.23 ± 0.06 % | 0.08 ± 0.03 % |
TGF-β | 0.14 ± 0.02 % | 0.32 ± 0.15 % |
IL-4 | 0.007 ± 0.003 % | 0.42 ± 0.24 % |
IL-10 | 0.81 ± 0.19 % | 3.36 ± 1.62 % |